🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6210873

Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207690

Troglitazone compounds for treating climacteric and cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207199

Process for making a particulate support matrix for making a rapidly dissolving dosage for

The Board of Regents of the University of Oklahoma · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207821

Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for

THE ARIZONA BOARD OF REGENTS · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6203793

Compositions and methods for treating thermal injury

The Board of Regents of the University of Texas System · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6201107

Cystic fibrosis gene

The Board of Regents Acting For and on Behalf of The University of Michigan · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6201165

Transgenic animal models for cardiac hypertrophy and methods of use thereof

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6197345

Thrombolytic agents and methods of treatment for thrombosis

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6197754

Suppression of tumor growth by a mini-E1A gene

The Board of Regents of the University of Texas System · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194206

Use of oligonucleotide telomerase inhibitors to reduce telomere length

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194176

Recombinant expression of proteins from secretory cell lines

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194481

Mechanically strong and transparent or translucent composites made using zirconium oxide n

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187296

Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

The Board of Regents of the University of Oklahoma · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187337

Rapidly dissolving dosage form

The Board of Regents of the University of Oklahoma · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184254

Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors

The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184224

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6183727

Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agen

THE ARIZONA BOARD OF REGENTS · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6177104

Particulate support matrix for making a rapidly dissolving dosage form

The Board of Regents of the University of Oklahoma · Granted Tue Jan 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6177547

Antibodies to P-selectin glycoprotein ligand

The Board of Regents of the University of Oklahoma · Granted Tue Jan 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6172212

Pea3 is a tumor suppressor

The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6171856

Methods and compositions relating to no-mediated cytotoxicity

The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6166193

Polynucleotides encoding MY1 receptor

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165990

Antisense polynucleotide

The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired